首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1402597

多克隆抗體市場：依類型、來源、應用、最終用戶、地區

Polyclonal Antibody Market, By Type, By Source, By Application, By End User,, By Region

出版日期: 2023年12月19日 | 出版商:

Coherent Market Insights | 英文 190 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球多株抗體市場規模預計將從 2023 年的 10.969 億美元增至 2030 年的 16.387 億美元，預測期內複合年成長率為 5.9%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	10.969 億美元
過去的資料	2018-2021	預測期	2023-2030
預測期複合年成長率	5.90%	2030年市場規模預測	16.387 億美元

圖 1. 2023 年按地區分類的多克隆抗體全球市場佔有率(%)

多克隆抗體是非特異性結合抗原上多個抗原決定位點的免疫球蛋白。它通常是透過將抗原注射到動物體內並收集含有免疫球蛋白的血清來產生的。各種慢性病和感染疾病患者病率上升、製藥和生物技術領域研發投資增加以及多克隆抗體擴大用於研究應用等因素預計將推動該市場的成長。然而，嚴格的產品核可監管指南可能會在一定程度上阻礙市場成長。多克隆抗體是一種源自多個 B 細胞免疫反應的異質抗體，每個 B 細胞辨識同一抗原上的不同表位。多克隆抗體由代表對抗原的先天免疫反應的抗體混合物組成。多克隆抗體用於一般研究應用。

市場動態：

由於慢性病和感染疾病病率上升以及各種研究應用的採用不斷增加等各種促進因素，預計全球多克隆抗體市場在預測期內將穩步成長。此外，診斷技術的持續技術創新以及向多克隆抗體的快速轉變（作為單株抗體的更便宜替代品）預計也將刺激需求。然而，與多克隆抗體精製和異質性相關的高成本以及嚴格的監管核准給市場帶來了重大挑戰。同時，先進精製技術、標記製程和重組抗體製造的發展將在預測期內創造成長機會。

本研究的主要特點

本報告對全球多克隆抗體市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
本報告還揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
本報告還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
該報告根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球多克隆抗體市場的主要企業。
該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球多克隆抗體市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球多克隆抗體市場的各種策略矩陣，將有助於相關人員做出決策。

市場動態
- 促進因素
增加產品發布
主要市場參與者之間的合作夥伴關係
- 抑制因素
生產多株抗體的成本較高
嚴格規定
- 市場機會
擴大多克隆抗體在診斷上的應用
採用重組多株抗體
影響分析
監管指引
產品發表會
主要進展
PEST分析
波特的分析
監管場景
併購
製造商收益
按國家/地區分類的醫療保健支出

第4章全球多株抗體市場-COVID-19的影響分析

整體影響
政府舉措
COVID-19 對市場的影響

第5章全球多株抗體市場，依類型，2018-2030

一抗
二抗

第6章全球多株抗體市場（依來源），2018-2030 年

兔子
山羊
羊
其他（大鼠等）

第7章全球多株抗體市場（依應用），2018-2030

學術研究
診斷
其他

第 8 章全球多株抗體市場，依最終使用者分類，2018-2030 年

學術研究所
製藥和生物技術公司
其他（診斷中心等）

第9章2018-2030年全球多株抗體市場（按地區）

北美洲
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
其他歐洲國家
亞太地區
中國
印度
日本
ASEAN
澳洲
韓國
其他亞太地區
中東
GCC
以色列
其他中東地區
非洲
北非
中部非洲
南非

第10章競爭形勢

Thermo Fisher Scientific Inc.
Santa Cruz Biotechnology, Inc.
GenScript
Merck KGaA
Bio-Rad Laboratories, Inc.
BioLegend, Inc.
GeneTex
ROCKLAND IMMUNOCHEMICALS, INC.
Abcam plc.
Creative Diagnostics
Crown Bioscience
Takara Bio Inc.
Geno Technology Inc.
IGY Immune Technologies and Life Sciences Inc.
EpigenTek Group Inc.
Takeda Pharmaceutical Company Limited
SAB Biotherapeutics

第11章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI4347

The global polyclonal antibody market size is expected to reach US$ 1,638.7 Mn by 2030, from US$ 1,096.9 Mn in 2023, exhibiting compound annual growth rate (CAGR) of 5.9% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 1,096.9 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	5.90%	2030 Value Projection:	US$ 1,638.7 Mn

Figure 1. Global Polyclonal Antibody Market Share (%), By Region, 2023

Polyclonal antibodies are immunoglobulin that bind nonspecifically to multiple epitopes of an antigen. They are commonly produced by injecting the antigen into an animal and harvesting the resulting serum containing the immunoglobulin. Factors such as the rising prevalence of various chronic and infectious diseases, increasing research and development investments in the pharmaceutical and biotechnology sectors, and the growing adoption of polyclonal antibodies for research applications are expected to drive the growth of this market. However, stringent regulatory guidelines for product approval may impede market growth to some extent. Polyclonal antibodies are a heterogeneous mix of antibodies derived from the immune response of multiple B-cells, in which each one recognizes a different epitope on the same antigen. Polyclonal antibodies are composed of a mixture of antibodies that represent the natural immune response to an antigen. Polyclonal antibodies are used in general research applications

Market Dynamics:

The global polyclonal antibody market is projected to grow at a steady pace during the forecast period owing to various driving factors such as rising prevalence of chronic and infectious diseases, and growing adoption in various research applications. Furthermore, ongoing innovations in diagnostic technology and a rapid shift towards polyclonal antibodies as an inexpensive alternative to monoclonal antibodies are expected to boost demand. However, the high costs associated with the purification and heterogeneity of polyclonal antibodies along with stringent regulatory approvals, pose major challenges to the market. On the other hand, development of advanced purification techniques, labeling processes, and recombinant antibody production creates growth opportunities during the forecast period

Key features of the study:

This report provides an in-depth analysis of the global polyclonal antibody market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global polyclonal antibody market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Santa Cruz Biotechnology, Inc., GenScript, Merck KGaA, Bio-Rad Laboratories, Inc., BioLegend, Inc., GeneTex, ROCKLAND IMMUNOCHEMICALS, INC., Abcam plc., Creative Diagnostics, Crown Bioscience, Takara Bio Inc., Geno Technology Inc., IGY Immune Technologies and Life Sciences Inc., EpigenTek Group Inc., Takeda Pharmaceutical Company Limited and SAB Biotherapeutics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global polyclonal antibody market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing global polyclonal antibody market

Detailed Segmentation:

Global Polyclonal Antibody Market, Type:
- Primary Antibody
- Secondary Antibody
Global Polyclonal Antibody Market, Source:
- Rabbits
- Goats
- Sheep
- Others
Global Polyclonal Antibody Market, By Application:
- Academic Research
- Diagnostics
- Others
Global Polyclonal Antibody Market, By End User:
- Academic & Research Institutes
- Pharmaceutical and Biotechnology Companies
- Others
Global Polyclonal Antibody Market , By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles
- Thermo Fisher Scientific Inc.
- Santa Cruz Biotechnology, Inc.
- GenScript
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- BioLegend, Inc.
- GeneTex
- ROCKLAND IMMUNOCHEMICALS, INC.
- Abcam plc.
- Creative Diagnostics
- Crown Bioscience
- Takara Bio Inc.
- Geno Technology Inc.
- IGY Immune Technologies and Life Sciences Inc.
- EpigenTek Group Inc.
- Takeda Pharmaceutical Company Limited
- SAB Biotherapeutics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Type
- Market Snippet, By Source
- Market Snapshot, By Application
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trend Analysis

Market Dynamics
- Drivers
Increasing product launch
Partnerships among key market players
- Restraints
The high costs associated with polyclonal antibody production
Stringent regulations
- Market Opportunities
Growing applications of polyclonal antibodies in diagnostics
Adoption of recombinant polyclonal antibodies
Impact Analysis
Regulatory Guidelines
Product launches
Key Development
PEST Analysis
PORTER's Analysis
Regulatory Scenario
Mergers and Acquisitions
Manufacturer Revenue
Healthcare Spending by Country

4. Global Polyclonal Antibody Market - COVID-19 Impact Analysis

Overall Impact
Government Initiatives
COVID-19 Impact on the market

5. Global Polyclonal Antibody Market, By Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Primary Antibody
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Secondary Antibody
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

6. Global Polyclonal Antibody Market, By Source, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Rabbits
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Goats
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Sheep
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Others (Rats, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Global Polyclonal Antibody Market, By Application, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Academic Research
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Diagnostics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

8. Global Polyclonal Antibody Market, By End User, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Pharmaceutical and Biotechnology Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Others (Diagnostic Centers, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

9. Global Polyclonal Antibody Market , By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country, 2019-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Platform, 2018- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018- 2030, (US$ Mn)
North Africa
Central Africa
South Africa

10. Competitive Landscape

Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Santa Cruz Biotechnology, Inc.
GenScript
Merck KGaA
Bio-Rad Laboratories, Inc.
BioLegend, Inc.
GeneTex
ROCKLAND IMMUNOCHEMICALS, INC.
Abcam plc.
Creative Diagnostics
Crown Bioscience
Takara Bio Inc.
Geno Technology Inc.
IGY Immune Technologies and Life Sciences Inc.
EpigenTek Group Inc.
Takeda Pharmaceutical Company Limited
SAB Biotherapeutics